Yueh‐Te Lin
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Mitochondrial Function and Pathology
Papers in
-
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 2
- RNA modifications and cancer 2
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Kou‐Juey Wu (3 shared papers)Kai‐Wen Hsu (4 shared papers)Allen Zhu (1 shared paper)Cai‐Ping Tan (1 shared paper)Chuan He (1 shared paper)Lulu Hu (1 shared paper)Ziyang Hao (1 shared paper)Jianzhao Liu (1 shared paper)
In The Last Decade
Yueh‐Te Lin
10 papers receiving 467 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 93
- Molecular Biology 311
- Immunology 62
- Oncology 74
- Rehabilitation 17
Countries citing papers authored by Yueh‐Te Lin
This map shows the geographic impact of Yueh‐Te Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueh‐Te Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueh‐Te Lin more than expected).
Fields of papers citing papers by Yueh‐Te Lin
This network shows the impact of papers produced by Yueh‐Te Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueh‐Te Lin. The network helps show where Yueh‐Te Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yueh‐Te Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 188 | |
| 2 | 2020 | 161 | |
| 3 | 2014 | 60 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 18 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 7 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 2 | |
| 10 | 2025 | 1 | |
| 11 | 2026 | 0 |
About Yueh‐Te Lin
Yueh‐Te Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Hepatology, having authored 11 papers that have together received 474 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Epigenetics and DNA Methylation (2 papers), Hepatitis B Virus Studies (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer-related Molecular Pathways (2 papers), Advanced Breast Cancer Therapies (2 papers), Hepatitis C virus research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (93 citations), Molecular Biology (311 citations), Immunology (62 citations), Oncology (74 citations) and Rehabilitation (17 citations). Yueh‐Te Lin has collaborated with scholars based in Taiwan, Malaysia and China. Frequent co-authors include Kou‐Juey Wu, Kai‐Wen Hsu, Allen Zhu, Cai‐Ping Tan, Chuan He, Lulu Hu, Ziyang Hao, Jianzhao Liu, Yawei Gao and Tong Wu. Their work appears in journals such as Viruses, Microbes and Infection, Journal of Biomedical Science, Molecular Cell and Biomedical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.